SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

50,945.10 -425.82
(-0.83%)

Dow Jones

7,674.56 -17.28
(-0.22%)

Hang Seng

68,949.71 2,195.99
(3.29%)

Nikkei 225

10,432.22 -173.78
(-1.64%)

Forex

USD-INR

95.97 0.01
(0.01%)

EUR-INR

108.89 -0.26
(-0.24%)

GBP-INR

126.98 -0.19
(-0.15%)

JPY-INR

0.61 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

43.07

1064.33

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.06

Back

lodha developers pvt ltd

Gala Global Products reports standalone net loss of Rs 0.49 crore in the June 2026 quarter

Jul 23,2026

Net Loss of Gala Global Products reported to Rs 0.49 crore in the quarter ended June 2026 as against net loss of Rs 2.07 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 as against Rs 0.01 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0	0.01	-100
OPM %	0	-18500.00	-
PBDT	-0.45	-2.01	78
PBT	-0.48	-2.07	77
NP	-0.49	-2.07	76

71,909.70 -570.59 ( -0.79%)

50,945.10 -425.82 (-0.83%)

7,674.56 -17.28 (-0.22%)

68,949.71 2,195.99 (3.29%)

10,432.22 -173.78 (-1.64%)

95.97 0.01 (0.01%)

108.89 -0.26 (-0.24%)

126.98 -0.19 (-0.15%)

0.61 0.00 (0.01%)